scholarly journals The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients

2021 ◽  
Vol 64 (6) ◽  
pp. 306
Author(s):  
Jen-Tang Sun ◽  
Chun-Yen Huang ◽  
Huang-Wen Tsai ◽  
Chia-Ying Liu ◽  
Tse-Hsuan Liu ◽  
...  
Antibiotics ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 788
Author(s):  
Marcello Covino ◽  
Alberto Manno ◽  
Giuseppe De Matteis ◽  
Eleonora Taddei ◽  
Luigi Carbone ◽  
...  

Background and Objectives. Fever is one of the most common presenting complaints in the Emergency Department (ED). This study aimed at evaluating the prognostic role of serum Procalcitonin (PCT) measurement among adult patients admitted to the ED with fever. Materials and Methods. This is a retrospective cross-sectional study including all consecutive patients admitted to ED with fever and subsequently hospitalized in a period of six-year (January 2014 to December 2019). Inclusion criteria were age > 18 years, fever (T ≥ 38 °C) or chills within 24 h from presentation to the ED as the main symptom, and availability of a PCT determination obtained <24 h since ED access. The primary endpoint was overall in-hospital mortality. Results. Overall, 6595 patients were included in the study cohort (3734 males, 55.6%), with a median age of 71 [58–81] years. Among these, based on clinical findings and quick sequential organ failure assessment (qSOFA), 422 were considered septic (36.2% deceased), and 6173 patients non-septic (16.2% deceased). After correction for baseline covariates, a PCT > 0.5 ng/mL was an independent risk factor for all-cause in-hospital death in both groups (HR 1.77 [1.27–2.48], and 1.80 [1.59–2.59], respectively). Conclusions. Among adult patients admitted with fever, the PCT assessment in ED could have reduced prognostic power for patients with a high suspicion of sepsis. On the other hand, it could be useful for sepsis rule-out for patients at low risk. In these latter patients, the prognostic role of PCT is higher for those with a final diagnosis of bloodstream infection.


2006 ◽  
Vol 5 (1) ◽  
pp. 134-134
Author(s):  
L SCELSI ◽  
L TAVAZZI ◽  
A MAGGIONI ◽  
D LUCCI ◽  
G CACCIATORE ◽  
...  

2007 ◽  
Vol 6 (1) ◽  
pp. 174-175
Author(s):  
O KHALEVA ◽  
N NIKITIN ◽  
A CLARK ◽  
K GOOD ◽  
A RIGBY ◽  
...  

2008 ◽  
Vol 7 ◽  
pp. 90-90
Author(s):  
M IACOVIELLO ◽  
P GUIDA ◽  
M CICALA ◽  
C GRANIERI ◽  
M BASILE ◽  
...  

Objective: the present study was aimed to evaluate the role of pharmaceutical services in improving the outcome of mineral bone disorder in patients with advanced chronic kidney disease. Methodology: One hundred and twenty patients with chronic kidney disease-mineral bone disorder (CKD-MBD) screened for eligibility, seventy-six patients enrolled in the study and randomly allocated into two groups: pharmaceutical care and usual care, both groups interviewed by the pharmacist using specific questionnaire for assessing the quality of life (QoL). All the drug related problems (DRPs) including drug-drug interactions (DDIs) were recorded by the pharmacist. Blood samples were collected and utilized for analyzing the levels of vitamin D, phosphorous, calcium, albumin and parathyroid hormone at baseline and three months after. The pharmaceutical care group received all the educations about their medications and how to minimize DRPs; improve the QoL. Additionally, the pharmaceutical intervention included correcting the biochemical parameters. Results: Pharmaceutical care significantly improved patients QoL and minimized DRPs and DDIs. It was also effective in improving the biochemical parameters. Conclusion: Pharmaceutical care has a positive impact on improving the outcome of patients with CKD-MBD through attenuating DRPs, improving the biochemical parameters and the QoL.


Sign in / Sign up

Export Citation Format

Share Document